• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cardinal Health Inc. filed SEC Form 8-K: Leadership Update

    3/5/26 7:07:59 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care
    Get the next $CAH alert in real time by email
    cah-20260302
    0000721371false00007213712026-03-022026-03-02

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 8-K
    Current Report
    Pursuant to Section 13 or 15(d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): March 2, 2026
    Cardinal Health, Inc.
    (Exact name of registrant as specified in its charter)
    Ohio1-1137331-0958666
    (State or other
    jurisdiction of incorporation)
    (Commission
    File Number)

    (IRS Employer
    Identification No.)
    7000 Cardinal Place, Dublin, Ohio 43017
    (614) 757-5000
    (Registrant’s telephone number, including area code)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common shares (without par value)CAHNew York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   p







    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    On March 2, 2026, Mary Scherer, Senior Vice President and Chief Accounting Officer, notified Cardinal Health, Inc. (the “Company”) that she intends to retire in February 2027. The Company will initiate a search process to identify her successor. Ms. Scherer will continue to serve as Chief Accounting Officer until her successor is identified and onboarded to ensure a smooth transition.



    Signatures
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    Cardinal Health, Inc.
    (Registrant)
    Date:March 5, 2026By:/s/ AARON E. ALT
    Aaron E. Alt
    Chief Financial Officer


    Get the next $CAH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CAH

    DatePrice TargetRatingAnalyst
    4/28/2026Outperform
    William Blair
    1/9/2026Neutral → Buy
    Citigroup
    12/9/2025$243.00Overweight
    Barclays
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    More analyst ratings

    $CAH
    SEC Filings

    View All

    SEC Form 11-K filed by Cardinal Health Inc.

    11-K - CARDINAL HEALTH INC (0000721371) (Filer)

    6/23/26 8:21:44 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form 11-K filed by Cardinal Health Inc.

    11-K - CARDINAL HEALTH INC (0000721371) (Filer)

    6/23/26 8:20:53 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SD filed by Cardinal Health Inc.

    SD - CARDINAL HEALTH INC (0000721371) (Filer)

    6/1/26 4:05:13 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardinal Health expands home care business with two tuck-in acquisitions

    DUBLIN, Ohio, July 20, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today it has entered into two definitive agreements that accelerate its at-Home Solutions' growth strategy. Cardinal Health will acquire the Diabetes Health business of AdaptHealth Corp. (NASDAQ:AHCO), and, in its entirety, Strive Medical, a multi-specialty supply provider with a focus on urology. Combined, the transactions total approximately $360 million in cash, subject to working capital adjustments."These strategic transactions build on the synergies created by our recent investments in home care," said Jason Hollar, Chief Executive Officer, C

    7/20/26 4:45:00 PM ET
    $CAH
    $AHCO
    Other Pharmaceuticals
    Health Care
    Medical/Nursing Services

    Cardiovascular Logistics Names Dr. Gary Kirsh Chief Executive Officer

    Veteran physician executive and former Solaris Health CEO to lead one of the nation's largest cardiology platformsNASHVILLE, Tenn., July 14, 2026 /PRNewswire/ -- Cardiovascular Logistics ("CVL" or the "Company"), one of the nation's leading cardiology management services organizations, today announced the appointment of Gary M. Kirsh, M.D. as Chief Executive Officer, effective immediately. Dr. Kirsh has served on CVL's Board of Directors since November 2025 and brings more than three decades of experience building and leading large, physician-led specialty platforms. Dr. Kirsh is the co-founder and former Chief Executive Officer of Solaris Health, which he built into the largest urology mana

    7/14/26 5:15:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2026 on August 11

    DUBLIN, Ohio, July 9, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2026 on August 11, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern. To access the webcast and corresponding slide presentation, visit Cardinal Health's Investor Relations page. No access code is required. Presentation slides and a webcast replay will be available on the Investor Relations page for 12 months.About Cardinal Health

    7/9/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Cardinal Health

    William Blair initiated coverage of Cardinal Health with a rating of Outperform

    4/28/26 7:43:38 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health upgraded by Citigroup

    Citigroup upgraded Cardinal Health from Neutral to Buy

    1/9/26 8:24:26 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Barclays initiated coverage on Cardinal Health with a new price target

    Barclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00

    12/9/25 8:43:24 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Hall Patricia Hemingway

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    4/17/26 7:26:16 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Chief Information Officer Greene Michelle D. sold $627,387 worth of shares (2,746 units at $228.47), decreasing direct ownership by 18% to 12,230 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    3/3/26 4:11:18 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Chief Financial Officer Alt Aaron E covered exercise/tax liability with 1,914 shares and sold $524,964 worth of shares (2,328 units at $225.50), decreasing direct ownership by 14% to 26,408 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    2/18/26 4:25:35 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Leadership Updates

    Live Leadership Updates

    View All

    Cardiovascular Logistics Names Dr. Gary Kirsh Chief Executive Officer

    Veteran physician executive and former Solaris Health CEO to lead one of the nation's largest cardiology platformsNASHVILLE, Tenn., July 14, 2026 /PRNewswire/ -- Cardiovascular Logistics ("CVL" or the "Company"), one of the nation's leading cardiology management services organizations, today announced the appointment of Gary M. Kirsh, M.D. as Chief Executive Officer, effective immediately. Dr. Kirsh has served on CVL's Board of Directors since November 2025 and brings more than three decades of experience building and leading large, physician-led specialty platforms. Dr. Kirsh is the co-founder and former Chief Executive Officer of Solaris Health, which he built into the largest urology mana

    7/14/26 5:15:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Appoints Patricia A. Hemingway Hall as Board Chair

    DUBLIN, Ohio, March 23, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that its Board of Directors has appointed Patricia A. Hemingway Hall to succeed Gregory B. Kenny as Chair of the Board following Mr. Kenny's retirement, effective immediately. Mr. Kenny has served on the Board since 2007 and as Chairman since 2018. During his tenure on the Board, Mr. Kenny supported the Company through periods of significant transformation, including strategic portfolio evolution and operational improvement initiatives."On behalf of the Board and our management team, we are d

    3/23/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    After Major Oncology Conference, All Eyes Turn to Industry Innovation

    USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

    6/12/25 9:00:00 AM ET
    $CAH
    $CTOR
    $CTXR
    Other Pharmaceuticals
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $CAH
    Financials

    Live finance-specific insights

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, May 5, 2026  /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2026 to shareholders of record at the close of business on July 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an opera

    5/5/26 4:40:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 11% to $60.9 billionGAAP1 operating earnings decreased 30% to $509 million; GAAP diluted EPS decreased 20% to $1.69Non-GAAP operating earnings increased 18% to $956 million; non-GAAP diluted EPS increased 35% to $3.17Cardinal Health raises and narrows fiscal year 2026 non-GAAP EPS guidance2 to $10.70 to $10.80Cardinal Health reduces debt and completes additional $250 million share repurchase, bringing FY26 repurchase total to $1.0 billionDUBLIN, Ohio, April 30, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today reported third quarter fiscal year 2026 revenues of $60.9 billion, an increase of 11% from the third quarter of fiscal year 2025.Third quarter GAAP operating earn

    4/30/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $CAH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/13/24 5:01:02 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    1/30/24 1:39:03 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

    SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

    2/14/23 12:37:58 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care